Tectonic Therapeutic, Inc. engages in discovery and development of therapeutic proteins & antibodies. The company was founded by Timothy A. Springer and Andrew Kruse in 2019 and is headquartered in Watertown, MA.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of TECX is 46.78 USD — it has decreased by −8.14% in the past 24 hours. Watch Tectonic Therapeutic, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Tectonic Therapeutic, Inc. stocks are traded under the ticker TECX.
TECX stock has risen by 7.42% compared to the previous week, the month change is a −1.65% fall, over the last year Tectonic Therapeutic, Inc. has showed a 176.45% increase.
We've gathered analysts' opinions on Tectonic Therapeutic, Inc. future price: according to them, TECX price has a max estimate of 79.00 USD and a min estimate of 69.00 USD. Watch TECX chart and read a more detailed Tectonic Therapeutic, Inc. stock forecast: see what analysts think of Tectonic Therapeutic, Inc. and suggest that you do with its stocks.
TECX reached its all-time high on Sep 26, 2018 with the price of 644.40 USD, and its all-time low was 6.72 USD and was reached on Oct 13, 2022. View more price dynamics on TECX chart. See other stocks reaching their highest and lowest prices.
TECX stock is 3.36% volatile and has beta coefficient of 0.93. Track Tectonic Therapeutic, Inc. stock price on the chart and check out the list of the most volatile stocks — is Tectonic Therapeutic, Inc. there?
Today Tectonic Therapeutic, Inc. has the market capitalization of 693.82 M, it has increased by 17.04% over the last week.
Tectonic Therapeutic, Inc. is going to release the next earnings report on Mar 20, 2025. Keep track of upcoming events with our Earnings Calendar.
TECX earnings for the last quarter are −1.20 USD per share, whereas the estimation was −0.84 USD resulting in a −42.86% surprise. The estimated earnings for the next quarter are −1.39 USD per share. See more details about Tectonic Therapeutic, Inc. earnings.
Tectonic Therapeutic, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
TECX net income for the last quarter is −17.72 M USD, while the quarter before that showed −12.67 M USD of net income which accounts for −39.82% change. Track more Tectonic Therapeutic, Inc. financial stats to get the full picture.
No, TECX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 30, 2024, the company has 13.00 employees. See our rating of the largest employees — is Tectonic Therapeutic, Inc. on this list?
Like other stocks, TECX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Tectonic Therapeutic, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Tectonic Therapeutic, Inc. technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Tectonic Therapeutic, Inc. stock shows the buy signal. See more of Tectonic Therapeutic, Inc. technicals for a more comprehensive analysis. If you're still not sure, try looking for inspiration in our curated watchlists.